home All News open_in_new Full Article

Novo chops Wegovy prices, but doctors still see affordability challenges for patients

Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain challenging for patients without insurance. The drugmaker said Monday that it has started selling higher doses of the injectable treatment for $349 a month to patients paying the full bill. That’s down from $499 and in […]


today 19 h. ago attach_file Science

attach_file Transport
attach_file Science
attach_file Other
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Other
attach_file Politics
attach_file Science
attach_file Transport
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Science
attach_file Economics
attach_file Economics
attach_file Science
attach_file Economics
attach_file Economics


ID: 2489825827
Add Watch Country

arrow_drop_down